Radiotracer targets β‑Amyloid for early Alzheimer’s detection
University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025
Editor's picks
Clinical Diagnostics
The global #CLINICAL24 2025 conversation has begun! Tell us your daily challenges and let's explore the solutions together
Explore topics
Drug Discovery
Transform your lab with advanced digitalized tools to accelerate drug discovery and development seamlessly
Explore feature
Life Sciences
Explore the latest technologies, resources, and expert insights driving the future of AI and automation in the lab
Explore feature
